Spain· ES:1201492001
TECARTUS 0,4 - 2 x 10e8 CELULAS DISPERSION PARA PERFUSION
A medicinal product containing brexucabtagén autoleucel, registered in Spain by Kite Pharma Eu B.V..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- brexucabtagén autoleucel
- Manufacturer
- Kite Pharma Eu B.V.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Brexucabtagén autoleucel in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesTECARTUSKite Pharma, Inc.
- CanadaTECARTUSGILEAD SCIENCES CANADA INC
- FinlandTecartusKite Pharma EU B.V.
- United KingdomTecartus 40million-200million cells/68ml dispersion for infusion bagsGilead Sciences Ltd
- BelgiumTecartus 0.4 10*8 cells/ml - 2 10*8 cells/mlKite Pharma EU
- NetherlandsTecartus 0.4-2.0 x 10^8 cellen, dispersie voor infusieKite Pharma EU B.V.
- NorwayTecartusKite Pharma EU B.V.
- PolandTecartusKite Pharma EU B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tecartus
- Liechtenstein · Tecartus
- Norway · Tecartus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9c767f5f-10d0-43de-9484-5c060b0899a0 GET /v1/drugs/9c767f5f-10d0-43de-9484-5c060b0899a0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1609110000000}",
"nregistro": "1201492001",
"substance": "brexucabtagén autoleucel"
}See everything about brexucabtagén autoleucel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.